Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor Day webcast, to take place from 10 am to 12 pm ET on Tuesday, March 27th in New York.

Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
10:00 (5 min.)     Welcome and Introductions    

Timothy L. EnnsSVP, Corporate Communications and Marketing
 
10:05 (15 min.) Corporate Overview

James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer
 
10:20 (15 min.) Financial Overview

Michael Molkentin, C.P.A.Chief Financial Officer and Corporate Secretary
 
10:35 (15 min.)

 

 

10:50 (20 min.)

Clinical UpdateSGI-110 & HMAs

 

Mohammad Azab, M.D.Chief Medical Officer

 

Jean-Pierre Issa, MDFels Institute of Cancer ResearchTemple University, Philadelphia, PA
 
11:10 (20 min.) AT 13387 & HSP90 inhibitors

Andrew Wagner, MD, PhDDana Farber Cancer Institute, Boston, MA
 

11:30 (15 min.)

 

 

11:45 (15 min.)

Research & DiscoveryPartnering & Corporate Development

 

Harren Jhoti, Ph.D.President and Director

 

Martin BucklandChief Business Officer
 
12:00 (5 min.) Closing Remarks

James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer

The times listed above are approximate and are subject to change.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.

Copyright Business Wire 2010

If you liked this article you might like

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's "Perilous Reversal" Stock

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)